Recovery & repair

BPC-157

Body Protection Compound

Research compoundEvidence: PreclinicalPeptideLimited human data

A peptide derived from a protein found in human stomach acid. Studied extensively for its ability to accelerate healing of muscles, tendons, and the gut lining.

Also known as: PL 14736, pentadeca

Status
BPC-157 is a research compound and not approved by the FDA for human use.
Evidence
Preclinical. Evidence comes from animal or lab studies; effects in people are not established.
Half-life
~4 hours
How it's taken
Subcutaneous injection or oral capsule
Mechanism
Tissue repair
Pathways
Angiogenesis

How BPC-157 works

Promotes the formation of new blood vessels (angiogenesis) at injury sites, increases growth factor activity, and modulates nitric oxide to support tissue repair. Works by enhancing your body's natural healing processes.

What research has looked at

Evidence level: Preclinical. Evidence comes from animal or lab studies; effects in people are not established. These are areas studied or reported, not promised effects.

Reported side effects and risks

Sources

  1. PubMed research on BPC-157 pentadecapeptide · NIH · National Library of Medicine
  2. DrugBank record for BPC 157 · DrugBank
  3. StatPearls / NCBI Bookshelf on BPC-157 · NCBI Bookshelf

Track BPC-157 in Peptide Vault

Log every dose, set reminders on your own schedule, rotate injection sites and keep your vials organized. Peptide Vault records what you enter. It doesn't recommend compounds or doses. iPhone, on-device.

Get Peptide Vault

Related compounds

BPC-157 FAQ

What is BPC-157?

A peptide derived from a protein found in human stomach acid. Studied extensively for its ability to accelerate healing of muscles, tendons, and the gut lining.

How does BPC-157 work?

Promotes the formation of new blood vessels (angiogenesis) at injury sites, increases growth factor activity, and modulates nitric oxide to support tissue repair. Works by enhancing your body's natural healing processes.

Is BPC-157 FDA approved?

No. BPC-157 is a research compound and not approved by the FDA for human use. Evidence level: preclinical. Evidence comes from animal or lab studies; effects in people are not established.

What is the half-life of BPC-157?

Reported half-life: ~4 hours.

How is BPC-157 taken?

Subcutaneous injection or oral capsule.

What side effects have been reported with BPC-157?

Reported in the sources: Generally well-tolerated in studies; Mild nausea in some users; Dizziness (rare); Limited long-term human safety data; Not FDA-approved for human use.

Educational summary compiled from the sources listed above. Not medical advice. Peptide Vault does not sell, source or recommend any compound. Talk to a qualified clinician before starting or changing anything.